Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial (Q45405108)
scientific article published in April 2007
Language:
Current Data About Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial
(P31) (Q13442814)
(P248)
(P698) 17434401
(P813) Thursday, December 14, 2017

(P50) (Q47006550)
(P1545) 3
(P1932) Christine Katlama

(Q56447702)
(P1932) Adriano Lazzarin
(P1545) 5

(Q60246105)
(P1545) 1
(P1932) Beatriz Grinsztejn
(P248)
(P698) 17434401
(P813) Thursday, December 14, 2017

(P304) 1261-1269
(P248)
(P698) 17434401
(P813) Thursday, December 14, 2017

(P407) (Q1860)

(P433) 9569
(P248)
(P698) 17434401
(P813) Thursday, December 14, 2017

(P478) 369
(P248)
(P698) 17434401
(P813) Thursday, December 14, 2017

(P577) Sunday, April 1, 2007
(P248)
(P698) 17434401
(P813) Thursday, December 14, 2017

(P921) (Q42824440)

(Q181600)

(Q643839)
(P887)

(Q421552)
(P887)

(P1433) (Q939416)
(P248)
(P698) 17434401
(P813) Thursday, December 14, 2017

(P1476) "Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial" (language: en)
(P248)
(P698) 17434401
(P813) Thursday, December 14, 2017

(P2093) Bach-Yen Nguyen
(P1545) 2
(P248)
(P698) 17434401
(P813) Thursday, December 14, 2017

Jose M Gatell
(P1545) 4
(P248)
(P698) 17434401
(P813) Thursday, December 14, 2017

Daniel Vittecoq
(P1545) 6
(P248)
(P698) 17434401
(P813) Thursday, December 14, 2017

Charles J Gonzalez
(P1545) 7
(P248)
(P698) 17434401
(P813) Thursday, December 14, 2017

Joshua Chen
(P1545) 8
(P248)
(P698) 17434401
(P813) Thursday, December 14, 2017

Charlotte M Harvey
(P1545) 9
(P248)
(P698) 17434401
(P813) Thursday, December 14, 2017

Robin D Isaacs
(P1545) 10
(P248)
(P698) 17434401
(P813) Thursday, December 14, 2017

Protocol 005 Team
(P1545) 11
(P248)
(P698) 17434401
(P813) Thursday, December 14, 2017

(P2860) (Q50105738)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960597-2
(P813) Thursday, January 7, 2021
(P887)

(Q36150601)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960597-2
(P813) Thursday, January 7, 2021
(P887)

(Q36682338)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960597-2
(P813) Thursday, January 7, 2021
(P887)

(Q82920244)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960597-2
(P813) Thursday, January 7, 2021
(P887)

(Q35095289)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960597-2
(P813) Thursday, January 7, 2021
(P887)

(Q39687529)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960597-2
(P813) Thursday, January 7, 2021
(P887)

(Q45471093)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960597-2
(P813) Thursday, January 7, 2021
(P887)

(Q28369295)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960597-2
(P813) Thursday, January 7, 2021
(P887)

(Q79390358)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960597-2
(P813) Thursday, January 7, 2021
(P887)

(Q31051809)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960597-2
(P813) Thursday, January 7, 2021
(P887)

(Q28183380)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960597-2
(P813) Thursday, January 7, 2021
(P887)

(Q44457921)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960597-2
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article published in April 2007

External Links
(P356) 10.1016/S0140-6736(07)60597-2
(P698) 17434401